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Abstract. Granulation tissue fibroblasts (myofibro- 
blasts) develop several ultrastructural  and biochemical 
features of smooth muscle (SM) cells, including the 
presence of microfilament bundles and the expression 
of a-SM actin,  the actin isoform typical of vascular 
SM cells.  Myofibroblasts have been proposed to play a 
role in wound contraction and in retractile phenomena 
observed during fibrotic diseases. We show here that 
the subcutaneous administration of transforming growth 
factor-ill  (TGFfll) to rats results in the formation of a 
granulation  tissue in which a-SM actin expressing 
myofibroblasts are particularly abundant.  Other cyto- 
kines and growth factors, such as platelet-derived 
growth factor and tumor necrosis factor-a, despite 
their profibrotic activity, do not induce a-SM actin in 
myofibroblasts. In situ hybridization with an a-SM ac- 
tin probe shows a high level of ot-SM actin mRNA ex- 
pression in myofibmblasts of TGFBl-induced granula- 
tion tissue.  Moreover, TGFfll induces cz-SM actin 
protein and mRNA expression in growing and quies- 
cent cultured fibroblasts and preincubation of culture 
medium containing whole blood serum with neutraliz- 
ing antibodies to TGFfll  results in a decrease of a-SM 
actin expression by fibmblasts in replicative and non- 
replicative conditions.  These results suggest that 
TGFfll plays an important role in myofibroblast differ- 
entiation during  wound healing and fibrocontractive 
diseases by regulating the expression of ot-SM actin in 
these cells. 
RANULATION tiSSUe  formation  and  contraction are 
critical steps for the healing  of an open wound (for 
review see Skalli and Gabbiani,  1988).  These pro- 
cesses are characterized by the involvement of a specialized 
mesenchymal cell with morphologic and biochemical fea- 
tares between those of the fibroblast and of the smooth mus- 
cle (SM) ~  cell, called myofibroblast  (Gabbiani  et al.,  1971; 
and for review see Schiirch et al., 1992). Myofibroblasts dis- 
appear in normal scars, but persist in hypertrophic scars and 
in fibrotic lesions of many organs, including stroma reaction 
to epithelial  tumors (Dvorak,  1986;  Skalli  et al.,  1989b; 
Sappino et al., 1990b; Kuhn and McDonald, 1991; Gressner 
and  Meyer,  1992),  where they are  allegedly involved  in 
retractile phenomena as well as in extracellular  matrix ac- 
cumulation (Gabbiani et al., 1976; Bazin et al., 1980; Gress- 
ner and Meyer,  1992;  and for review see Schiirch  et al., 
1992). The hallmark of the myofibroblastic phenotype is the 
expression of ot-SM actin (Skalli et al., 1989b; Darby et al., 
1990), the actin isoform present in SM cells and myoepithe- 
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lial  cells,  and particularly  abundant  in vascular  SM cells 
(Rubenstein,  1990; McHugh et al.,  1991). Many aspects of 
myofibroblast biology are still mysterious, such as the factors 
regulating the expression of ot-SM actin by these cells. Previ- 
ous work from our laboratory has shown that growth factors 
known to elicit fibroblast replication  in vivo and in vitro- 
e.g., PDGF or tumor necrosis factor-ix (TNFo0-do not in- 
duce a-SM actin expression  by these cells (Rubbia-Brandt 
et al., 1991; Desmouli~re et al., 1992b). Here we report that 
the local  administration  of transforming  growth factor-ill 
(TGFfll) in vivo results in the formation of a granulation  tis- 
sue in which ot-SM actin expressing myofibroblasts are par- 
ticularly abundant.  Moreover,  TGFfll induces tx-SM actin 
expression in growing and quiescent cultured fibroblasts and 
neutralizing  antibodies to TGFfll inhibit partly the expres- 
sion of o~-SM actin in fibroblasts cultured in the presence of 
whole blood serum (WBS) but not of plasma-derived serum 
(PDS). These results suggest that TGFfll plays an important 
role in myofibroblast  differentiation  during wound healing 
and fibrosis. 
Materials and Methods 
In Vivo  Experimental Procedures 
All experiments were performed on 6-wk-old female Wistar rats.  Seven 
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The Journal of Cell Biology, Volume 122, Number 1, July 1993 103-111  103 animals per group were used.  Osmotic minipumps (model 2001;  Alza 
Corp., Palo Alto, CA) were filled under sterile conditions with TGFB1 iso- 
lated from hnman platelets (Sigma Immnnochemicals, St. Louis, MO; and 
a gift of Dr. A. B. Roberts, Laboratory of Chemoprevention, National Can- 
cer Institute, Bethesda, MD), or recombinant-human "I'GF~I (gift of Dr. 
A. B. Roberts). Recombinant muriue TNFtx (gift of Dr. G. Grau, Depart- 
ment of Pathology, University of Geneva, Geneva, Switzerland, with an en- 
dotoxin contamination <1 ng/ml, Grau et ai., 1987; Piguet et al., 1990) was 
used.  Minipumps were implanted subcutaneously into the back of the 
animals, through a channel (,,o3-cm long) prepared immediately before with 
blunt sterile scissors. Incisions were always performed over the sacral re- 
gion. In controls, the pumps were filled with carder solution. Pump outlets 
were oriented cranially.  After 7 d of continuous delivery, the pumps were 
removed and their content verified. Animals in which the pumps were not 
empty were discarded. Newly formed granulation tissues surrounding per- 
fusion pumps were collected systematically in the region close to the outlet 
and in the middle of the pump; they were either frozen in liquid isopentane 
immersed in liquid nitrogen and stored at -80"C for indirect immunofluores- 
cence and for biochemical studies or fixed for light and EM. 
Drugs were delivered at the following doses per day: 'I'GFB1, 140 rig; 
TNFa,  1 #g (Desmouli~re et al., 1992b).  The substances were brought to 
final concentration in sterile 150 mM NaCI just before implantation. 
Cells and Culture Conditions 
Cells were cultured in MEM (Gibco AG, Basel, Switzerland) supplemented 
with 100 U/ml penicillin, 100/zg/ml streptomycin and 2 mM L-glutamine, 
and containing 10% FCS (Gibeo AG). Rat and human PDS and WBS were 
prepared according to Vogel et al. (1978).  Cultures were incubated at 370C 
in a  humidified atmosphere of 5%  COz/95%  air with medium changes 
twice a week. 
Rat fibroblasts were obtained from explants of subcutaneous tissue of  the 
back. Human fibroblasts were obtained from explants of normal subcutane- 
ous tissue of breast skin from women undergoing reduction mammoplasty 
for cosmetic reasons. We have also used the HFL-1 cell line derived from 
human embryo lung (American Type Culture Collection, Rockville, MD) 
and bovine aortic endothelial cells (Gabbiani et al.,  1984). 
Passage 5 cells were treated with TGF/31 in different culture conditions. 
In most cases, doses between 5 and 10 ng/ml which has been shown to in- 
duce c~-SM actin in human arterial SM cells (Bj6rkerud, 1991) were used. 
Medium was removed 24 h after plating and fibroblasts were incubated for 
7 d with MEM plus serum alone or supplemented with TGF/31. To study 
TGF/31 effects on growth-arrested cells, the cytokine was added for 7 d to 
cultures where FCS had been substituted with 10% PDS and in which no 
growth  was  observed  (Desmouli~re  et  al.,  1992b),  or  to  a  confluent 
monolayer of fibroblasts. The cell number was determined by performing 
haemocytometer cell count. A total of seven experiments were done using 
cell populations from different donors. 
To neutralize the activity of  TGF~, chicken (IgY; Research & Diagnostic 
Systems, Inc., Minneapolis, MN) or turkey (gift of Dr.  A. B.  Roberts; 
Flanders et ai., 1988) neutralizing antibodies to TGFBI  (1-15 t~g/ml) were 
added to the culture medium and incubated for 1 h at room temperature. 
As a control, the same protein concentration of immnnoglobulins from non- 
immunized chickens or turkeys was used. 
Immunofluorescence Staining 
Double immnnofluorescence was performed using anti-c~SM-1,  a  mouse 
mAb specific for c~-SM actin (Skulli et al., 1986) and either a rabbit poly- 
clonal anti-actin antibody recognizing all  actin  isoforms (Skalli  et  al., 
1986), an affinity-purified  rabbit polyclonal anti-SM myosin antibody (Ben- 
zonana et al., 1988) or an affinity-purified  rabbit polyclonal anti-desmin an- 
tibody (Kocher et al.,  1984).  TRITC-labeled goat anti-mouse Ig (Nordic 
Immunological Laboratories, Tllburg, The Netherlands) and diehlorotria- 
zinyl amino fluorescein (DTAF)-conjugated goat anti-rabbit IgG (Jackson 
ImrnunoResearch Labs, Inc., West Grove, PA) were used for the second 
step. To minimize cross reactions, second antibodies were passed on solid 
immnnoabsorbants of rat serum cross-linked with glutaraldehyde. Control 
staining was performed using non-immune IgGs at the same dilution used 
for the primary antibody. After washing, preparations were mounted and 
observed on a Zeiss Axiophot microscope (Carl Zeiss, Oberkechen, FRG) 
equipped  with  epiillumination  and  specific  filters  for  rhodamine  and 
fluorescein (Carl  Zeiss).  Photographs were taken,  using Plan Neofluar 
40×/0.90 objective, on T-Max Kodak black and white film (Eastman Ko- 
dak, Rochester, NY). 
Cells were fixed in methanol for 5 rain at -20°C. Immnnolluorescence 
was performed in culture dishes or on cells detached by trypsinization and 
cytocentrifuged at 125 g for 5 rain (Shandon Scientific-Co., London, UK). 
Cell counts were performed using the interactive image analysis system 
VIDAS (Kontron Elektronik GmbH, Eching, FRG) connected to an In- 
tensified CCD camera type FMC-4005  (AVT-Horn, Aalan, FRG). 
Cryostat sections (3-4-/~m thick) of tissue samples were fixed in acetone 
at  -200C for 5 rain and air dried at room temperature for 2 h. Adjacent 
frozen sections were stained with hematoxylin and eosin in order to corre- 
late histologic with immunohistochemical evaluations. 
In Situ Hybridization 
A 33-met synthetic oligonucleotide (dTAGCACACAACTGTGAATGTTTT- 
GTGGATCAGC-OH)  derived from the rat c~-SM actin 3'-untranslated re- 
gion was used as single-stranded template (Bochaton-Piallat et al., 1992). 
An ll-mer synthetic oligonucleotide (dATCCACAAAAC-OH) was used as 
primer and extended by means of Klenov fragment of DNA polymerase I 
(sp act >3,000  U/rag; Boehringer Mannheim GbmH,  Mannheim, FRG) 
with  deoxyribonucleotide triphosphates (except dCTP)  and  32p-labeled 
dCTP (sp act >3,000 Ci/mM; Amersham Corp., Arlington Heights, IL) ac- 
cording to Sambrook et al. (1989).  The labeled oligonucleotide (29 mer) 
was run on a 12% polyacrylamide sequencing gel with 7 M urea (Bio-Rad 
Laboratories AG, Glattbrugg, Switzerland). After gel autoradiography, the 
band was located, cut out, and eluted overnight in sterile distilled water with 
shaking. 
Cryostat sections (3--4-t~m thick) of tissue samples were deposited on 
slides pretreated with 3-aminopropyl-triethoxysilane (Flulm Chemic AG, 
Buchs, Switzerland), fixed in 4% paraformaldehyde (Merck, Darmstadt, 
FRO at 4°C for 20 min, dehydrated, and stored at -80*(2 until use. The 
sections were incubated in 0.25 % acetic anhydride (Fluka Chemie AG) in 
0.1 M triethanolamine-HCl, pH 8.0 (Flulm Chemic AG), for 10 rain, and 
then prehybridized in 50% deionized formamide (Flulm Chemia AG), 30 
mM phosphate buffer, 0.02 % Denhardt's solution (Sambrook et ai., 1989), 
1 mg/ml denatured salmon sperm DNA (Sigma Chemical Co.), 0.6  M 
NaC1, and 5 mM EDTA (Fhika Chemic AG) at 30"C for 4 h. Hybridization 
was performed in the same solution with the labeled oligonucleotide at 30"C 
overnight. Slides were washed in 2x  SSC (SSC is 0.15 M NaCl, 0.015 M 
sodium citrate) for 1 min at room temperature, and then in Ix SSC at 40"C 
with shaking for 1 h and rinsed in ethanol. Slides were dipped into NTB2 
autoradiographic emulsion (Eastman Kodak) and stored at 4"C. Prepara- 
tions were observed on a Zeiss Axiophot microscope. Photographs were 
taken, using Plan Neoflnar 40×/0.90 objective, on Ektachrome 64T color 
film. Densitometric evaluation of labeling was performed using the interac- 
tive image analysis system VIDAS (Kontron Elektronik GmbH) connected 
to an Intensified CCD camera type FMC-4005 (AVT-Horn). 
Light and Electron Microscopy 
For light microscopy, tissue samples were fixed in ethanol and embedded 
in paraffin wax. Sections (5-#m thick) were cut and stained with hematoxy- 
lin and eosin, or with Van Gieson (for collagen)-elnstin. 
For EM, tissues were cut in small cubes, fixed 4 h at room temperature 
in  2%  glntaraldehyde (Merck,  Darmstadt,  FRO)  in  0.1  M  cacodylate 
(Merck) buffer and stored in buffer overnight at 4°C. They were postfixed 
in 2 % OsO4 (Merck), dehydrated in graded ethanols, and embedded in 
Epon 812 (Fluka Chemie AG, Buchs, Switzerland). Semithin sections were 
cut arid stained with methylene blue. Representative areas were selected for 
thin sections. These were collected on copper grids, double stained with 
uranyl acetate (Merck) and lead citrate (Merck),  and examined with a 
Philips 400 electron microscope. 
For immunoelectron microscopy, specimens were cut in small cubes, 
fixed for 5 h at room temperature in 2 % paraformaldehyde (Merck) and 
0.5% glutaraldehyde (Merck) in 0.1 M phosphate buffer, and then rinsed 
overnight in the same buffer. The next day, tissues were dehydrated through 
graded ethanols at decreasing temperatures, up to -35"C in a LTE 020 Bal- 
zers apparatus (Balzers Union, Vaduz, Liechtenstein) and maintained at this 
temperature all through the subsequent infiltrations in Lowicryl K4M resin 
(Chemische  Werke Lowi, Waidkraiburg, FRG). Polymerization was carried 
out in UV light first at -35°C for 24 h, and then at room temperature for 
additional 48 h. Representative regions  of  the tissues were selected on semi- 
thin sections and cut in thin sections which were collected on Formvar- 
coated nickel grids covered by a carbon film. The grids were first incubated 
for 30 rain at room temperature in PBS (150 m_M NaC1 in 10 mM phosphate 
buffer, pH 7.2)  containing 5% normal goat serum (Aurion, Wageningen, 
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Water Fish Skin gelatin 40%; Aurion), and then for 2 h on drops of anti-a- 
SM-1 diluted at 1:10 in PBS containing 1% normal goat serum, 0.8% BSA, 
and 0.1% gelatin, and then rinsed three times for 10 rain in PBS containing 
BSA  and  gelatin.  The  second  incubation  was  performed  with  goat 
anti-mouse IgG conjugated to  0.8-nm  gold  particles  (GP-Ultra Small; 
Aurion) diluted at 1:100 in PBS containing normal goat serum, BSA, and 
gelatin for 2 h at room temperature. They were rinsed three times for 15 
rain in PBS containing BSA and gelatin,  three times for 5 rain in PBS, and 
finally rinsed in sterile distilled water. Amplification of the gold staining 
was performed by reaction with colloidal silver (Aurion) for 15 rain at room 
temperature according to Danscher (1981). Grids were counterstained with 
uranyl acetate and lead citrate and examined in a Philips 400 electron mi- 
croscope. 
SDS-PAGE and Immunoblotting 
For SDS-PAGE,  cells were  trypsinized and,  after haemocytometer cell 
counts, were mixed in buffer containing 1% SDS  (Bio-Rad  Laboratories 
AG), 1% DTT (Fluka Chemic AG),  1 mM PMSF (Merck), 1 mM Nc~-P- 
Tosyl-L-arginine methylester (Sigma Immuncchemicals) in 0.4 M Tris HCI, 
pH 6.8 (Laemmli,  1970).  The samples were immediately sonicated and 
boiled for 3 rain. Protein content was determined according to Bradford 
(1976).  40/~g protein was electrophoresed on a 5-20% gradient gel and 
stained with Coomassie blue. For quantification  of total actin, gels were 
scanned  with  a  computerized  laser  beam  densitometer  (Genofit  SA, 
Geneva, Switzerland)  as previously  described (Kocher et al.,  1985; Des- 
mouli~re  et al.,  1991). 
Western blotting with anti-ccSM-l,  a mouse rnAb-specific for ~-SM ac- 
tin, was performed according to Skalli et al. (1986). Briefly, 5 to 20 tLg pro- 
tein were electrophoresed on a 5-20% gradient gel. Separated proteins were 
transferred to nitrocellulose filters  (Towbin et al.,  1979) which were in- 
cubated with anti-ccSM-l.  A  second incubation was done with a  rabbit 
anti-mouse IgG conjugated  with HRP (Nordic Immunological Laborato- 
ries). Enhanced chemiluminescence (Amersham International pie,  Buck- 
inghamshire, England) was used for detection. 
RNA Extraction and Northern Blot Hybridization 
Cultured cells were scraped from Petri dishes using a rubber policeman and 
homogenized in a  sterile solution, pH 7.4,  containing 4.5 M  guanidine 
isothioeyanate  (Fluka Chemie AG),  50 mM EDTA (Fluka Chemie AG), 
0.1  M  fl-mercaptoethanol (Fluka Chemie AG),  25  mM  sodium citrate 
(Merck) and 2% N-lauroylsarcosine  (Sigma Immunochemicals) with a sy- 
tinge through a 23-gauge needle as previously described (Koeher and Gab- 
biani, 1987).  RNA was purified by ultracentrifugation through a cushion 
of 5.7 CsCI (Chirgwin et al., 1979). The RNA pellets were resuspended in 
10 mM Tris HCI, pH Z4, 0.5% SDS (Bio-Rad Laboratories AG) and 1 mM 
EDTA (Fluka Chemie AG), extracted twice with saturated phenolchloro- 
form, and then once with chloroform-isoamylalcohoi  (24:1, vol/vol).  The 
RNA was ethanol precipitated, resuspended in sterile water, and stored at 
-70"C. 
Samples (5-20/~g) of total RNA were denatured with glyoxal, separated 
by eleetrophoresis in a  1% agarose gel, and then transferred overnight on 
a Hybond-N filter (Amersham Corp.). Next day, the membrane was baked 
for 2 h at 80"C under vacuum and stained with 0.04%  methylene blue in 
0.5 M Na-acetate to verify correct loading and transfer. Hybridization was 
performed with a  riboprobe derived from the coding region of the rat 
a-SM actin mRNA which recognizes all actin mRNAs (total actin probe 
pRAoaA-C; K.ocher and Crabbiani, 1987) or with synthetic  oligonucleotides 
specific either for rat a-SM actin (Bochaton-Piallat  et al., 1992) or for hu- 
man a-SM actin (Barret and Benditt, 1987) mRNAs respectively.  For the 
riboprobe, 32P-labeling was carried out aceordin~g to Melton et al. (1984) 
and Northern blot hybridization was performed as previously described 
(Kocher and Gabbiani, 1987) with minor modifications.  The Northern blots 
were washed twice for 20 min at 58°C in 3× SSC and 2x Denhardt's solu- 
tion (Sambrook et al.,  1989), and subsequently three times in 0.2× SSC, 
O. 1% SDS (Bio-Rad Laboratories AG), and 0.1% Na-pyrophospbate,  pH 7.0, 
for 20 rain at 70"C. s2P-labeling of the oligonucleotides  and hybridization 
were performed according to Sambrook et al. (1989). Filters were exposed 
to Kodak X-Omat SO-282 film at -70"C between intensifying screens and 
developed  films were analyzed by means of computerized densitometric 
scanning (Desmouli~re  et al.,  1991; Bochaton-Piallat et al.,  1992). 
Results 
Effect of TGFfJl In Vim 
7 d after implantation, the reactive connective tissue around 
all pumps appeared macroscopically as a capsule, and was 
always distinct from the non-reactive subcutaneous tissue 
(Desmouli~re et al.,  1992b).  In  controls,  the pumps  re- 
mained mobile and the capsule was very thin. In animals 
treated with TNFo~, the capsules were adherent to the subcu- 
taneous tissue and clearly thicker than the control capsule. 
In animals treated with TGFfll, the capsules were adherent 
to the subcutaneous tissue and less thick than those induced 
by TNFa. 
At light microscopic examination, the newly formed cap- 
sules had different features according to the treatment. Tis- 
sue surrounding control pumps consisted of fibroblasts, new 
blood vessels, and extracellular matrix accompanied by a 
very weak inflammatory reaction. After TNFe~ treatment, a 
typical granulation tissue was observed; in addition, mono- 
nuclear cells and few polymorphonuclear cells were present, 
particularly close to the surface  facing the osmotic pump 
(Desmouli~re et ai., 1992b). With TGFfll, pronounced neo- 
vascularization and extensive collagen deposits surrounding 
fibroblastic cells were seen; leucocyte infiltration was mild. 
After immunofluorescence staining, the walls of arteri- 
oles, venules and capillaries were positive for ,-SM actin 
and desmin (Fig. 1), as well as for SM myosin. In fibroblastic 
cells of capsules surrounding pumps delivering NaCI and 
TNFu (Fig.  1, a  and b), c~-SM actin and desmin stainings 
were never detected. In the presence of TGF~ (Fig.  1 c), 
a diffuse positive staining for a-SM actin was observed in 
each  animal;  the  cellular  staining was  often clearly dis- 
tributed in bundles and most pronounced in the tissue por- 
tion close to the pump. A weak but definite staining for des- 
rain was also observed (Fig.  1 d). 
By in situ hybridization with the ot-SM actin probe a high 
labeling was localized on the vessel walls, particularly in ar- 
terioles, of subcutaneous tissue (Fig. 2 a). In granulation tis- 
sue,  autoradiographic silver grains were diffusely distrib- 
uted at a high density compared to the adjacent unaffected 
subcutaneous  tissue  (Fig.  2  b).  Densitometric  analysis 
showed that in o~-SM actin expressing granulation tissue and 
in vessel wails, OD values were increased to 172  +  3 % (P 
< 0.001) and 217  +  3% (P < 0.001), respectively, compared 
to the levels of the subcutaneous tissue. 
EM  showed  that  fibroblasts  of  control  capsules  were 
characterized by a smooth nuclear outline and a cytoplasm 
rich in RER, Golgi apparatus, and mitochondria. In TNFot- 
treated tissues, in addition to such fibroblasts, several myo- 
fibroblastic cells were present showing typical cytoplasmic 
microfilament bundles or stress fibers (Desmouli~re et al., 
1992b).  After TGFfll treatment, stress fibers, often located 
beneath the plasmalemma and parallel to the main axis of the 
cell, were present in a large proportion of fibroblastic cells. 
Dense bodies were scattered within these bundles. Microfila- 
ment bundles were also located along cytoplasmic exten- 
sions,  frequently observed in these myofibroblasts. These 
cells showed also a dilated RER suggesting their involvement 
in an active synthetic activity. 
Immunogold EM  with  anti-otSM-1  was  performed  on 
TNFo~- and TGFfll-induced capsules.  As described previ- 
Desmouli~re et al.  TGFfll  and u-Smooth  Muscle Actin  105 Figure 1. Double immunoflu- 
orescence stainings for a-SM 
actin (a and c) and desmin (b 
and d) of capsules from ani- 
mals  treated  with  TNFa  (a 
and b) or with TGF~I (c and 
d).  Vessels are  labeled  for 
both c~-SM actin and desmin. 
Numerous fibroblasts positive 
for a-SM actin (c) and few pos- 
itive also for desmin (d) are 
recognized in  TGF~l-treated 
tissue. Bar, 10/~m. 
ously (Skalli et al.,  1989a;  Darby et al.,  1990), pericytes 
were  always  labeled.  TNFc~-induced  granulation  tissue 
showed fibroblastic cells containing microfilament bundles 
not decorated (Fig. 3 a) or decorated by few gold granules 
(Desmouli~re et al.,  1992b). In granulation tissue induced 
by TGF/~I, practically all myofibroblasts were stained with 
anti-otSM-1  with many colloidal silver particles localized 
over extensive stress fibers (Fig.  3 b). 
Effect of TGF{31 on Cultured Fibroblasts 
In 10% FCS and 10% WBS, we observed an antiproliferative 
effect of TGF/ffl (10 ng/ml, 65.1  +  1.3%  and 40.1  ±  2.2% 
of control conditions). 
Immunoblot analysis showed that the expression of ot-SM 
actin was increased in the presence of TGF/~I when human 
subcutaneous fibroblasts were cultured in medium plus 10% 
FCS (Fig. 4, a-d) or 10% WBS. This increase was higher 
when TGF/~I was added to sparse subconfluent cells com- 
pared to confluent growth-arrested cells (data not shown). 
Moreover, an increase of o~-SM actin expression by TGF~I 
treatment was observed in fibroblasts cultured in PDS (Fig. 
4, e-h). A dose-response study with a confluent culture of 
human subcutaneous fibroblasts ("~3  x  106 cells per  100 
mm Petri dish) showed that TGF~I was able to induce a-SM 
actin expression at a dose of 1 ng/ml (8 ml per Petri dish). 
By  densitometric  scanning  of Western  blots,  values  ex- 
pressed as percentage of the 10% PDS value were 380 for 
10 ng/ml, 430 for 5 ng/ml, 330 for 2 ng/ml, and 270 for 1 
ng/ml (standard errors of means were always <5 % of the 
values). 
Quantitative changes of total actin content were examined 
by densitometric analysis of SDS-PAGE (Fig. 4, a, b, e, and 
f). Total actin contents were similar in 10% FCS and 10% 
PDS cultured fibroblasts. TGF~ treatment did not modify 
significantly the total actin content which was 13.8 ±  0.4% 
of total cellular protein in subcutaneous adult rat fibroblasts, 
and 12.7  ±  0.3%  in human subcutaneous fibroblasts. 
Immunofluorescence studies (Fig. 5) showed that the in- 
crease of ot-SM actin expression by TGFfiq treatment in hu- 
man subcutaneous fibroblasts cultured in PDS was at least 
in  part due to a  significant increase in the percentage of 
Figure 2. c~-SM  actin mRNA ex- 
pression  in  TGF/~l-treated con- 
nective tissue revealed by in situ 
hybridization. As internal  control, 
a significant labeling is present in 
the vessel wall of a subcutaneous 
arteriole (a). b in c~-SM actin ex- 
pressing granulation  tissue (right), 
a density of silver grains compa- 
rable to that present in the arteri- 
ole is observed, compared to the 
underlying  subcutaneous  tissue 
(left) where the labeling is lower. 
Bar, 10/~m. 
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cutaneous  fibroblasts measured  by Western blot analysis.  Cells 
were cultured in the presence of 10% FCS (a-d) or 10% PDS (e-h) 
without (a, c, e, and g) or with (b, d, f, and h; 5 ng/ml) TGF/31. 
Densitometric scanning of Coomassie blue-stained  gels (a, b, e, 
and f) shows that the percentage of actin per total protein is not 
significantly modified in the presence of 10% FCS or 10% PDS and 
by TGFfll treatment (for values see Results). Immunoblotting after 
SDS-PAGE (c, d, g, and h) shows that TGF/31 increases the ot-SM 
actin content of growing and quiescent human fibroblasts. A, actin. 
Figure 3.  lmmunoelectron  microscopic details of myofibroblasts 
from TNFtx (a)- and TGF/51 (b)-treated capsules after labeling for 
ot-SM actin. Some myofibroblasts of TNFa induced capsule show 
no or very weak labeling (a) of stress fibers. Silver particles are 
abundant over stress fibers of myofibroblasts in granulation tissue 
produced by TGFB1 treatment (b). Bar, 1 /zm. 
ot-SM actin positive cells (45.3 +  2.1%) compared to control 
cells (7.5  -1- 0.8%, P <  0.001).  No significant modifications 
concerning the number of desmin-positive cells (<10%) or 
the number of SM myosin positive cells (<15%) were ob- 
served. When fibroblasts were treated by TGF/31 (10 ng/ml 
or less) in the presence of 10% PDS, we never observed cell 
death as previously described for cultured SM cells (Bj6r- 
kerud,  1991). 
We examined also the influence of FCS, WBS, and PDS 
on the expression of ot-SM  actin in cultured human fibro- 
blasts. An increase oftx-SM actin expression was observed in 
the presence of 1% serum (FCS or WBS) compared to 10% 
serum. Densitometric scanning of  Western blots showed that 
in fibroblasts cultured in the presence of 1% WBS, the level 
of ot-SM actin expression was clearly increased compared to 
the value obtained for fibroblasts cultured in 10% WBS (Fig. 
6). Neutralizing antibodies to TGF/~I abolished the increase 
of ot-SM actin expression observed in 10% PDS plus 1 ng/ml 
TOF/~I.  Moreover,  preincubation  of  medium  containing 
10% WBS (inducing cell replication) or 1% WBS (maintain- 
ing fibroblasts quiescent with high levels of c~-SM actin) with 
neutralizing antibodies to TGF~ resulted in a decrease of 
a-SM actin expression in both 10% WBS (P< 0.01) and 1% 
WBS (P <  0.001,  Fig. 6). When neutralizing antibodies to 
TGF/~I  were incubated with medium containing PDS,  no 
changes in the expression of  o~-SM actin were observed com- 
pared to controls. 
A  marked increase of a-SM actin expression by TGF/5'I 
was also observed in HFL-1 cells. By densitometric scanning 
of Western blots, values expressed as percentage of the 10 % 
FCS value were 3,070  for 5 ng/ml, 2,740 for 2 ng/ml, and 
2,070 for 1 ng/ml. In these culture conditions, no effect was 
observed with a dose of  0.1 ng/ml. Cultured bovine aortic en- 
dothelial cells did not express ot-SM actin normally and upon 
treatment with TGF/31. 
Hybridization with the total actin probe pRAootA-C of to- 
tal RNA preparations from human subcutaneous fibroblasts 
resulted in two bands corresponding to fl- +  3'- (2.1 kb) and 
ct- (1.7 kb) actin mRNAs (Kocher and Gabbiani,  1987). In 
cells cultured in 10% PDS and treated with TGF/~I (5 ng/ml) 
for 7 d, the 1.7-kb band was markedly increased compared 
to control cells. An induction of  the 2.1-kb band was also ob- 
served (Leofet al., 1986). Densitometric scanning of  North- 
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c~-SM actin expression in hu- 
man subcutaneous fibroblasts 
fixed after cytocentrifugation 
and stained by means of dou- 
ble immtmofluorescence  for to- 
tal actin (a and c) and c~-SM 
actin  (b  and  d).  Cells  were 
cultured without (a and b) or 
with (c and d; 5 ng/ml) TGF/51 
in the presence of 10% PDS. 
TGF/31 increases significantly 
the proportion  of c~-SM actin 
containing cells. Bar, 10 ~m. 
ern blots hybridized with the total actin probe showed that 
after TGF/31 treatment, total actin mRNA was increased to 
215  +  3% of the level of controls. Densitometric scanning 
of Northern blots hybridized with our specific oligonucleo- 
tide showed that after TGFB1 treatment, a-SM actin mRNA 
was increased to 380 +  2% of the level of controls (Fig. 7). 
Similar results  showing an important action of TGFB1  on 
a-SM  actin  mRNA  expression  were  also  obtained  in  rat 
fibroblasts (data not shown). 
Discussion 
Many  morphological and  functional  features  of the  myo- 
fibroblast have been recently defined (for review see Schiirch 
et al.,  1992). Thus, it is established that during the modula- 
tion from fibroblast to myofibroblast, this cell acquires the 
expression of o~-SM actin and, albeit more rarely, of desmin 
(Skalli et al.,  1989b), but almost never of SM myosin heavy 
chains (Benzonana et al.,  1988;  Eddy et al.,  1988).  There 
is  a  correlation between  the  expression  of these  SM  cell 
markers by myofibroblastic cells and the presence of an ac- 
tive retractile fibrosis in the affected tissues (Darby et al., 
1990;  Schmitt-Griiff et al.,  1991).  Myofibroblasts are also 
considered to be responsible, at least in part, for the produc- 
tion of connective tissue matrix components which charac- 
terizes fibrotic situations (Ramadori et al.,  1987;  Schiifer et 
al.,  1987;  Skalli and Gabbiani, 1988) or stroma reaction to 
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Figure 6. Effect of  neutralizing antibodies to TGF/31 on c~-SM actin 
expression in human fibroblasts. Cells were cultured in the pres- 
ence of 10% WBS or 1% WBS without or with neutralizing anti- 
bodies (NA). Densitometric  scanning of Western blots shows that 
preincubation  of medium containing  WBS  with  NA to TGF/31 
results in a decrease of c~-SM actin expression in both replicating 
(10% WBS) and non-replicating  (1%  WBS) fibroblasts. The effect 
is  more important  in non-replicating  fibroblasts.  Values are ex- 
pressed  as mean percentage  (+SEM) of the  10% WBS value. 
Figure 7. Effect of TGFfll on ac- 
tin mRNA expression  in human 
subcutaneous fibroblasts. Hybrid- 
ization of Northern blots with the 
oligonucleofide  specific  for hu- 
man a-SM  actin  mRNA shows 
that  c~-SM actin  mRNA expres- 
sion is increased in TGFBl-treated 
cells  (b;  5  ng/ml)  compared  to 
control cells (a). 
The Journal of Cell Biology, Volume 122, 1993  108 1985).  The problem of the origin of myofibroblasts has not 
been yet fully clarified. It has been suggested that myofibro- 
blasts  of wounds arise locally from quiescent fibroblasts 
(Darby et al., 1990) but they may also originate from more 
specialized cells  such as  perisinusoidal cells in the liver 
(Ballardini et al.,  1988;  Ramadori, 1991; Schmitt-Gr~iff et 
al., 1991), mesangial cells in the glomerulus (Johnson et al., 
1991),  interstitial cells in the lung septa (Mitchell et al., 
1989; Kapanci et al., 1990; Kuhn and McDonald, 1991), and 
perivascular SM cells (Shum and McFarlane,  1988;  for a 
detailed review on this subject see Schiirch et al., 1992). All 
these observations support the view that, whatever the ori- 
gin,  myofibroblastic modulation is  an  important  step  in 
wound healing and in pathological phenomena characterized 
by tissue retraction and fibrosis. However,  little is known 
about the factors regulating on one hand the differentiation 
and the disappearance of myofibroblasts and on the other 
hand their functional activities. We show here that TGFfll 
stimulates in vivo the modulation of fibroblasts into ot-SM 
actin  expressing myofibroblasts.  It has  been  recently re- 
ported that wounds in adult rats treated with a neutralizing 
antibody to TGF/3 presented a  reduced inflammatory re- 
sponse and restitution of the dermal architecture without 
scarring, thus suggesting that TGFfl plays a role in wound 
retraction and scar formation in vivo (Shah et al.,  1992). 
Moreover, inhibition of TGFfl by decorin significantly re- 
duced scarring in an experimental model of glomerulone- 
phritis (Border et al.,  1992). 
When several growth factors were tested in vivo for their 
capacity to generate ot-SM actin rich myofibroblasts, it was 
observed that interleukin-1 (IL-1), PDGF, and TNFc~ did not 
possess  the  capacity of inducing ot-SM  actin expression, 
which however was  exerted by granulocyte macrophage- 
colony-stimulating factor (GM-CSF).  GM-CSF activity is 
allegedly indirect since this cytokine, differently  from TGFfll, 
had no effect on ot-SM actin expression on cultured fibro- 
blasts (Rubbia-Brandt et al., 1991). After GM-CSF local ap- 
plication, the appearance of ot-SM actin-rich myofibroblasts 
is  preceded  by  an  accumulation of macrophage  clusters 
(Vyalov et al., 1993) which conceivably could produce one 
or more ot-SM  actin expression inducing factors,  among 
which  TGFfll  is  a  likely  candidate.  In  the  same  work 
(Rubbia-Brandt et al.,  1991), we had described that TGFfl 
has no action of a-SM actin expression in vivo: since our 
present results have been repeatedly obtained with TGFfll 
isolated from human platelets supplied by two sources (see 
Materials and Methods) and with recombinant TGFfll, we 
assume that TGFfll used for the previous experiment was 
contaminated by a substance inhibiting ot-SM actin expres- 
sion. Work is in progress in our laboratory to identify this 
contaminant. 
We  have  also  recently  reported  (Desmouli~re  et  al., 
1992b) that heparin stimulates the expression of a-SM actin 
in fibroblastic cells, both in vivo and in vitro. However, hepa- 
rin acts only when fibroblasts undergo replication, suggest- 
ing that it produces a selection of ot-SM actin-positive cells 
rather than an activation of the et-SM actin gene. It has been 
shown that heparin potentiates the biological action of TGFfl 
(McCaffrey et al., 1989, 1992). Indeed many similarities ex- 
ist between the action of heparin or heparin-like molecules 
and TGF/~ particularly on cell proliferation and extracellular 
matrix synthesis (McCaffrey et al.,  1992). 
In addition to its action in vivo,  our results  show that 
TGF/$1 stimulates de novo the synthesis of ot-SM actin in cul- 
tured fibroblasts growing in the presence of 10% FCS as well 
as in quiescent fibroblasts after confluence in the presence 
of 10% FCS or subconfluent in the presence of PDS. In this 
last case, the percentage of  fibroblasts expressing a-SM actin 
was increased about six times compared to controls. We do 
not know whether TGFfll induces the transcription of ot-SM 
actin mRNA or modifies the degradation of such mRNA in 
a cell which already expresses it. Further studies are neces- 
sary to clarify this point. In any event it appears that TGF~I 
is up to now the only substance known to be capable of 
stimulating c~-SM actin synthesis in cultured quiescent fibro- 
blastic cells. TGF/3 increases also the expression of  ct-SM ac- 
tin in cultured SM cells (BjOrkerud,  1991). We have previ- 
ously shown that a population of cultured fibroblasts always 
contains a subpopulation of a-SM actin positive cells, even 
after cloning, suggesting that the expression of ot-SM actin 
is a constitutive feature of a fibroblast population in vitro, 
where serum and hence TGF/~ are present (Desmouli~re et 
al., 1992a).  TGFfl could represent one of the main regula- 
tors of this fibroblastic feature. This is supported by the ob- 
servation that incubation of medium containing exogenous 
TGFfll in addition to PDS as well as of medium containing 
WBS, but not of medium containing only PDS with neu- 
tralizing antibodies to TGFfll reduces significantly the ex- 
pression of a-SM actin in both replicating and quiescent 
fibroblasts.  It remains to be established if and how TGFfl 
modulates the fibroblastic phenotype in vivo during wound 
healing. We suggest that during this phenomenon, fibroblast 
replication and movement as well as stress fiber formation 
(resulting in myofibroblasts without o~-SM actin [for a dis- 
cussion of the heterogeneity of myofibroblastic phenotype 
see Sappino et al., 1990b])  are under the control of factors 
other than TGFfl.  This cytokine could play a  role subse- 
quently by stimulating collagen and a-SM actin synthesis 
and thus allowing the formation of a typical granulation tis- 
sue with ot-SM actin-rich myofibroblasts, such as seen in rats 
8 to 15 d after an experimental wound (Darby et al., 1990). 
The study of growth factor and cytokine activities has al- 
lowed an important progress in the understanding of wound 
healing mechanisms (Deuel et al., 1991; Kovacs,  1991; Rob- 
son,  1991; Pierce et al.,  1991, 1992).  We know that many 
growth  factors  and  cytokines are  capable  of stimulating 
fibroblast replication in vitro (Chert and Rabinovitch, 1990; 
Thornton et al.,  1990;  Kumar et al.,  1991) and in  vivo 
(Rubbia-Brandt et al.,  1991; Desmouli&e et al.,  1992b), 
collagen synthesis in vitro (Roberts et al., 1986) and fibrosis 
formation in vivo (Krummel et al.,  1988;  Kovacs,  1991). 
However, with the exception of TGFfl, these growth factors 
do not affect directly ~-SM actin expression by fibroblasts 
(Rubbia-Brandt et al., 1991), hence they presumably are not 
responsible for the differentiation of typical myofibroblastic 
cells. Extracellular matrix components are also capable of 
modifying the  phenotype and  the  functional  features  of 
fibroblasts (Gospodarowicz et al.,  1980;  Kao et al.,  1984; 
Desmouli~re et al., 1992b).  However the only extracellular 
matrix component capable of  intluencing ot-SM actin expres- 
sion in these cells,  i.e.,  heparin,  acts by selecting ot-SM 
actin-positive cells among replicating fibroblasts (Desmou- 
li~re et al.,  1992b). 
It is well established that TGFfl plays a role in the differen- 
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Sporn and Roberts, 1991; Border and Ruoslahti,  1992; Mas- 
sagu6 et al., 1992). TGF/3 has also been shown to stimulate 
collagen, fibronectin (Ignotz  and Massagut, 1986; Roberts 
et al.,  1986), and protease  inhibitors  (Laiho et al.,  1986) 
synthesis and to inhibit collagenase production (Chiang and 
Nilsen-Hamilton,  1986;  Matrisian et al.,  1986;  for review 
see Sporn et al.,  1987). The fibrosis  stimulating activity of 
TGF/3 is generally interpreted on the fight of its action on ex- 
tracellular matrix compounds (Border et al.,  1992;  Shah et 
al., 1992; Sporn and Roberts, 1992). The demonstration that 
TGF/51 promotes the synthesis  of a structural protein  such 
as ,-SM actin, which is a well accepted differentiation marker 
(Sappino et al., 1990a; McHugh et al., 1991), confirms and 
extends the notion of the role of TGF/~ in both differentiation 
and fibrosis. Taken together with our results, all these prop- 
erties of TGF/51 support the assumption (Sporn et al., 1987) 
that this cytokine plays a crucial  role in granulation  tissue 
evolution and particularly in myofibroblast formation, possi- 
bly after that other cytokines or growth factors (e.g., PDGF, 
IL-1,  and  TNFc=) have  directly  or  indirectly  stimulated 
fibroblast proliferation. 
Our results may help in the understanding of the mecha- 
nisms involved in the production and control of granulation 
tissue and are in accordance with the possibility that, at least 
in certain cases, cell differentiation is not controlled by ge- 
netically  irreversible steps, as it has been assumed for a long 
time,  but is modulated locally by microenvironmental  in- 
fluences exerted by cytokines, growth factors and extracellu- 
lar matrix components (Blau and Baltimore,  1991). 
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